[The treatment of atypical manias with finlepsin-retard].
The article presents results of clinical trial of finlepsine-retard. Objectivized parameters characterizing the time course of psychopathologic symptoms were studied in certain concentrations of finlepsine and beta-endrofin in blood serum. Atypical maniac states do not easily respond to therapies but finlepsine-retard gives the modern psychopharmacotherapy a new horizon.
Dziub
H K
HK
Chuprykov
A P
AP
Harnyts'ka
A S
AS
Protsyk
V O
VO
Os'kina
V M
VM
Benes'ko
O I
OI
D000328:Adult; D018692:Antimanic Agents / Q000097:blood / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D002220:Carbamazepine / Q000097:blood / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
D018692:Antimanic Agents; D003692:Delayed-Action Preparations; D002220:Carbamazepine